نتایج جستجو برای: multidrug resistant tuberculosis

تعداد نتایج: 291703  

Journal: :The Lancet. Infectious diseases 2015
Matthew Bates Victor Mudenda Aaron Shibemba Jonas Kaluwaji John Tembo Mwila Kabwe Charles Chimoga Lophina Chilukutu Moses Chilufya Nathan Kapata Michael Hoelscher Markus Maeurer Peter Mwaba Alimuddin Zumla

BACKGROUND Patients with subclinical tuberculosis, smear-negative tuberculosis, extrapulmonary tuberculosis, multidrug-resistant tuberculosis, and asymptomatic tuberculosis are difficult to diagnose and may be missed at all points of health care. We did an autopsy study to ascertain the burden of tuberculosis at post mortem in medical inpatients at a tertiary care hospital in Lusaka, Zambia. ...

Journal: :The New England journal of medicine 2006
David A J Moore Carlton A W Evans Robert H Gilman Luz Caviedes Jorge Coronel Aldo Vivar Eduardo Sanchez Yvette Piñedo Juan Carlos Saravia Cayo Salazar Richard Oberhelman Maria-Graciela Hollm-Delgado Doris LaChira A Roderick Escombe Jon S Friedland

BACKGROUND New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and multidrug-resistant tuberculosis. Rapid, sensitive detection of tuberculosis and multidrug-resistant tuberculosis in sputum has been demonstrated in proof-of-principle studies of the microscopic-observation drug-susceptibility (MODS) assay, in which broth cultures are examined microscopically t...

2006
Eva Nathanson Catharina Lambregts-van Weezenbeek Michael L. Rich Rajesh Gupta Jaime Bayona Kai Blöndal José A. Caminero J. Peter Cegielski Manfred Danilovits Marcos A. Espinal Vahur Hollo Ernesto Jaramillo Vaira Leimane Carole D. Mitnick Joia S. Mukherjee Paul Nunn Alexander Pasechnikov Thelma Tupasi Charles Wells Mario C. Raviglione

Evidence of successful management of multidrug-resistant tuberculosis (MDRTB) is mainly generated from referral hospitals in high-income countries. We evaluate the management of MDRTB in 5 resource-limited countries: Estonia, Latvia, Peru, the Philippines, and the Russian Federation. All projects were approved by the Green Light Committee for access to quality-assured second-line drugs provided...

2009
Isabelle Devaux Kristin Kremer Herre Heersma Dick Van Soolingen

Molecular surveillance of multidrug-resistant tuberculosis (MDR TB) was implemented in Europe as case reporting in 2005. For all new MDR TB cases detected from January 2003 through June 2007, countries reported case-based epidemiologic data and DNA fingerprint patterns of MDR TB strains when available. International clusters were detected and analyzed. From 2003 through mid-2007 in Europe, 2,49...

2010

Tuberculosis (TB) remains a major global health problem, particularly in many of the developing countries including India. Some of the factors that have substantially contributed to the number of multi-drug resistant tuberculosis (MDRTB) and extensively drug resistant tuberculosis (XDRTB) cases both in general and among HIV infected persons arethe delay in the diagnosis as well as delayed deter...

2018
Daniela Munro-Rojas Esdras Fernandez-Morales José Zarrabal-Meza Ma Teresa Martínez-Cazares Aurora Parissi-Crivelli Javier Fuentes-Domínguez Marie Nancy Séraphin Michael Lauzardo Jorge Alberto González-Y-Merchand Sandra Rivera-Gutierrez Roberto Zenteno-Cuevas

BACKGROUND Mexico is one of the most important contributors of drug and multidrug-resistant tuberculosis in Latin America; however, knowledge of the genetic diversity of drug-resistant tuberculosis isolates is limited. METHODS In this study, the genetic structure of 112 Mycobacterium tuberculosis strains from the southeastern Mexico was determined by spoligotyping and 24-loci MIRU-VNTRs. FI...

Journal: :Epidemiology and infection 2004
S J Conaty A C Hayward A Story J R Glynn F A Drobniewski J M Watson

Drug-resistant tuberculosis can be transmitted (primary) or develop during the course of treatment (secondary). We investigated risk factors for each type of resistance. We compared all patients in England and Wales with isoniazid- and multidrug-resistant tuberculosis in two time-periods (1993-1994 and 1998-2000) with patients with fully sensitive tuberculosis, examining separately patients wit...

Journal: :Pediatrics 2006
Peter C Drobac Joia S Mukherjee J Keith Joseph Carole Mitnick Jennifer J Furin Hernán del Castillo Sonya S Shin Mercedes C Becerra

OBJECTIVES The goals were to describe the management of multidrug-resistant tuberculosis among children, to examine the tolerability of second-line antituberculosis agents among children, and to report the outcomes of children treated for multidrug-resistant tuberculosis in poor urban communities in Lima, Peru, a city with high tuberculosis prevalence. METHODS A retrospective analysis of data...

Journal: :Elisabeth health jurnal 2022


 Introduction : Multidrug-resistant TB (MDR TB) is a type of that resistant to at least two the first-line antimicrobials, isoniazid (INH) and rifampin (RMP), with or without resistance other antimicrobials. The factors causing MDR-TB were age, gender, education level, income, occupation, medication adherence, knowledge, attitudes, stigma, smoking habits, role PMO, side effects treatment....

Journal: :Jurnal Biologi Tropis 2022

The tuberculosis treatment control program is constrained by the outbreak of TB that resistant to anti-tuberculosis drugs (OAT), especially multidrug-resistant tuberculosis. Confirmation drug resistance really needs be done in each area considering there are variations phenotypes and genotypes region through laboratory tests such as molecular biology tests. Aim study determine prevalence Mycoba...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید